Drawing for NAVOYCDS

USPTO serial 97621899

NAVOYCDS

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
REID, MONICA R
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with NAVOYCDS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecilia R. Dickson

Cecilia R. Dickson The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software and hardware for medical and diagnostic use for monitoring and analyzing patient data points from the health records; Downloadable computer software for evaluating, verifying, monitoring, analysis and management of medical data; Downloadable computer software for medical equipment, in particular in diagnostic and prognostic equipments indicating level risk of sepsis; Downloadable AI software for diagnostics, monitoring and data analysis; Downloadable computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analyzing, organizing and displaying data; Downloadable computer software for enabling the secure and efficient transfer of tests and data between patients and caregivers; Downloadable medical software applications for body fluid monitoring; Downloadable computer software for monitoring, tracking, inserting, archiving, analyzing, preparing of reports, comparing and sharing of medical information and data; Computer hardware with preinstalled software for providing a risk score to health care providers with regards to a patients sepsis risk; Electronic data recorders for collection and management of physiological and medical data, namely data originating from electronic health records; Electronic data recorders for measuring, detecting, receiving, monitoring, transmitting and processing of data, namely data originating from electronic health recordsACTIVE—
010Medical equipment for diagnostics, examination, analyzing and monitoring patient health conditions, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical apparatus and instruments for diagnosing, monitoring and analyzing of patients who are at risk for or who have medically destabilizing conditions, systemic inflammatory diseases, sepsis and infection, other immunological conditions or organ dysfunction or failure, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical equipment and apparatus equipped with communication platforms for continuous and remote monitoring of physiological parameters, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Diagnostic and prognostic apparatus for medical purposes, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical equipment for analyzing, storing, transmitting and organizing of medical information, namely medical equipment for monitoring a patient's breathing, oxygen level, blood pressure, body fluids, blood cells, blood levels, level of drugs, body balance, level of consciousness, and infections; Medical diagnostics instruments and apparatus for the analysis of bodily fluidsACTIVE—
042Computer-aided diagnostic testing services, namely, proving reagent sample testing and diagnostic services for other for scientific research purposes; Software as a service (SaaS) services featuring software for machine learning, deep learning for use in deep neural networks; Software as a service (SaaS), namely, hosting a computer software platform enabling connectivity and exchange of data between scientific, technical, diagnostic and laboratory devices for the transmission of medical data; Software as a service (SaaS) for early detection, diagnosis, prognosis and treatment of diseases; Scientific and technical consultancy and support for customers purchasing diagnostic software, namely, troubleshooting in the nature of diagnosing computer software problems; Blood analysis; Online non-downloadable computer software and hardware for medical and diagnostic use for monitoring and analyzing patient data points from the health records; Online non-downloadable computer software for evaluating, verifying, monitoring, analysis and management of medical data; Online non-downloadable computer software for medical equipment, in particular in diagnostic and prognostic equipments indicating level risk of sepsis; Online non-downloadable AI software for diagnostics, monitoring and data analysis; Online non-downloadable computer software for use with medical patient monitoring, diagnostic and prognostic equipment for receiving, processing, transmitting, analyzing, organizing and displaying data; Online non-downloadable computer software for enabling the secure and efficient transfer of tests and data between patients and caregivers; Online non-downloadable computer software applications for body fluid monitoring; Online non-downloadable computer software for monitoring, tracking, inserting, archiving, analyzing, preparing of reports, comparing and sharing of medical information and data; Information, advice and consultancy services relating to the aforementioned servicesACTIVE—
044Diagnostic and prognostic medical services; Medical analysis for the diagnosis and treatment of persons; Providing medical information, namely, preparation of medical reports for use in decision-making; Provision of medical information from medical reports for use in decision-making; Medical care, namely monitoring of patients; Medical testing and analysis for diagnostic, prognostic or treatment purposes; Provision of medical information for treatment of individuals; Information and consultancy relating to the analysis of medical data for the treatment of individuals; Providing medical information from remote locations via devices that feed information to the website that is being processed, exchanged and accessed in real time by users for medical staff and medical patients via a website; Consultancy relating to medical health care; Consultancy, advisory and information services relating to all the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 24, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 24, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 16, 2026EXT5SOU EXTENSION 5 FILED—
Jul 16, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2026EX4GSOU EXTENSION 4 GRANTED—
Jan 23, 2026EXT4SOU EXTENSION 4 FILED—
Jan 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 19, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2025EX3GSOU EXTENSION 3 GRANTED—
Jun 18, 2025EXT3SOU EXTENSION 3 FILED—
Jun 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 26, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 26, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 26, 2025EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Feb 26, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 20, 2024EX2GSOU EXTENSION 2 GRANTED—
Dec 20, 2024EXT2SOU EXTENSION 2 FILED—
Dec 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 20, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 20, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 20, 2024EXT1SOU EXTENSION 1 FILED—
Jun 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 23, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 28, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 28, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 8, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 24, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 20, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 21, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 20, 2023DOCKASSIGNED TO EXAMINER—
Oct 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance